A carregar...
AT-23 A PHASE II STUDY OF LAPATINIB AND DOSE-DENSE TEMOZOLOMIDE (TMZ) FOR ADULTS WITH RECURRENT EPENDYMOMA: A CERN CLINICAL TRIAL
BACKGROUND: Ependymoma is an uncommon adult primary CNS tumor. Initial treatment includes extensive resection often followed by but there is no standard treatment for recurrent disease. Molecular studies show most tumors have ErbB2 overexpression and unmethylated MGMT promoter status. We developed a...
Na minha lista:
Main Authors: | , , , , , , , , , , , , |
---|---|
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
Oxford University Press
2014
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4217801/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nou237.23 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|